KIF5B and neoplasm: Results of Western blotting showed that BYS10 dose-dependently degraded RET protein levels in the Ba/F3-KIF5B-RET-V804L xenograft model with immune deficiency and significantly inhibited the phosphorylation of RET kinase in tumor tissues.